Related Experiment Video
Updated: Mar 14, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Early Therapeutic Response Predicts Outcome in Chronic Constipation: A Multicenter Prospective Observational Study
Tadayuki Oshima1,2,3, Seiji Futagami4,3, Yoshimasa Tanaka5,3
1Department of Gastroenterology and Hepatology, Hyogo Medical University, Nishinomiya, Japan.
Early treatment response in chronic constipation is key. Patients not responding to therapy within two weeks are likely to have poorer outcomes at four weeks, highlighting the importance of early efficacy assessment.
Area of Science:
- Gastroenterology
- Clinical Pharmacology
Background:
- Chronic constipation affects quality of life and is common in clinical practice.
- Predictors of treatment efficacy for chronic constipation are not well understood.
- Identifying these predictors is crucial for optimizing patient care.
Purpose of the Study:
- To identify factors that predict successful treatment outcomes in patients with chronic constipation.
- To determine if early treatment response can predict long-term efficacy.
Main Methods:
- A multicenter, prospective observational study was conducted.
- Patients with chronic constipation (moderate to severe) were assessed using the CC-TEST questionnaire.
- Multivariate analyses identified predictive factors based on patient's impression, symptom intensity (NRS), and spontaneous bowel movement (SBM) frequency at 2 and 4 weeks post-treatment.
Main Results:
- 97 patients received constipation medications, showing significant symptom improvement at 2 and 4 weeks.
- Early treatment response at 2 weeks, specifically non-responsiveness, was a significant predictor of poorer patient impression and outcomes for NRS and SBM.
- Incorporating 2-week non-responsiveness improved the predictive accuracy for 4-week treatment efficacy.
Conclusions:
- The therapeutic response observed at two weeks is the most significant predictor of subsequent treatment response at four weeks.
- Early assessment of treatment efficacy in chronic constipation is crucial for predicting long-term outcomes.
- This finding can help clinicians tailor treatment strategies more effectively.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

